Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 1 Months Ended 3 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2021
Mar. 31, 2021
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Sep. 30, 2021
Sep. 30, 2022
Dec. 31, 2021
Cash flows from operating activities:                
Net income (loss)   $ 0 $ 1,343,981 $ 5,028,624 $ (665,953) $ (666,572) $ 9,790,293  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
Offering costs allocated to warrants           505,566 0  
Change in fair value of warrant liability     (928,000)   0 0 (10,208,000) $ 11,600,000
Interest earned on investments held in Trust Account     (1,058,397)   (193) (193) (1,396,280)  
Changes in operating assets and liabilities:                
Prepaid assets           (915,147) 526,253  
Other liabilities           0 395,829  
Taxes payable           112,329 232,008  
Due to related party           667 30,000  
Accrued offering costs and expenses           40,619 14,750  
Net cash used in operating activities           (922,731) (615,147)  
Cash flows from investing activities:                
Principal deposited in Trust Account           (234,600,000) 0  
Cash withdrawal from Trust Account to pay taxes           0 294,568  
Net cash provided by (used in) investing activities           (234,600,000) 294,568  
Cash flows from financing activities:                
Proceeds from Private Placement Warrants           11,700,000 0  
Proceeds from Public Offering, net of costs           225,400,000 0  
Proceeds from sale of Class B common stock           25,000 0  
Proceeds from issuance of promissory note to related party           110,000 0  
Payment of deferred offering costs           (490,543) 0  
Repayment of promissory note to related party           (110,000) 0  
Net cash provided by financing activities           236,634,457 0  
Net change in cash           1,111,726 (320,579)  
Cash, beginning of period   $ 0   $ 1,041,948   0 1,041,948  
Cash, end of the period $ 1,041,948   721,369   $ 1,111,726 1,111,726 721,369 $ 1,041,948
Supplemental disclosure of non-cash financing activities:                
Deferred underwriting commissions payable charged to additional paid in capital           8,050,000 0  
Class A Common Stock Subject To Possible Redemption           213,225,023 0  
Accretion of carrying value to redemption value $ 21,374,977   $ 796,360     21,374,977 860,040  
Initial classification of warrant liability           $ 17,632,000 $ 0